Now starring to look very very attractive
DHA from 2020 in Europe is a massive tailwind as regulatory support + Bellamys have shifted to organic and totally shifted the supply chain (need CLV as its a monopoly)
Classic strong moat, low input cost business business to buyers. A Munger favourite.
It should do well
Ann: Change in Director's Interest Notice, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CLV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
-0.005(1.01%) |
Mkt cap ! $60.11M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 49.5¢ | 49.0¢ | $8.983K | 18.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32789 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 44797 | 1 |
View Market Depth
| Last trade - 15.45pm 15/11/2024 (20 minute delay) ? |
| CLV (ASX) Chart |
